Do you recommend SGLT2 inhibitors for patients with Fabry disease and proteinuria despite ACEi/ARB use?

Like most other nephrologists, I have had very little experience with Fabry's disease (1 patient for a couple of months over the last 26 years). If enzyme replacement is indicated and given, and an ACE-ARB is already instituted, I don't see a problem with starting SGLT-2 in addition.